Sunnyvale-Based Aptus Endosystems Lands $25 Million in Funding

Sunnyvale, Calif. -- Aptus Endosystems, a Sunnyvale-based medical device company developing technology for endovascular aneurysm repair (EVAR), said on Wednesday it has raised $25 million in a new round of funding, led by Synergy Life Science Partners. Previous backers US Venture Partners and Longitude Capital Management also participated in the round, which the company will use to expand commercialization of its HeliFX Aortic Securement System in the U.S. and Europe. "We will judiciously utilize these funds to expand the use of HeliFX in targeted markets and introduce new aortic repair products, all while approaching profitability," James Reinstein, the company's president and CEO. http://www.aptusendosystems.com http://www.aptusendosystems.com/news/2012/062712.html